Product Code: ETC6186290 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The non-24-hour sleep-wake disorder drug market in Australia is expanding due to increasing awareness and diagnosis of circadian rhythm disorders. Pharmaceuticals like melatonin receptor agonists and sleep aids are driving market growth.
The non-24-hour sleep-wake disorder drug market in Australia is driven by increasing diagnosis of sleep disorders and growing awareness about circadian rhythm disorders. Rising availability of pharmacological treatments such as melatonin receptor agonists, increasing adoption of behavioral therapy, and growing investment in sleep research are supporting market growth.
The non-24-hour sleep-wake disorder drug market in Australia is constrained by high drug development and clinical trial costs. Regulatory requirements for drug approval and patient safety increase production complexity. Limited awareness among healthcare providers and patients reduces market demand. High treatment costs and limited insurance coverage further restrict patient access.
The non-24-hour sleep-wake disorder drug market in Australia is growing due to increased diagnosis and treatment of this circadian rhythm disorder. Melatonin receptor agonists and sleep aids are commonly used treatments. Investment opportunities exist in developing new-generation sleep-wake cycle regulators, improving drug efficacy, and expanding patient access to specialized sleep clinics. Growth in sleep health awareness and research into circadian biology is driving market expansion.
Non-24-hour sleep-wake disorder drugs are classified as prescription medications under TGA guidelines. The PBS covers certain medications used for circadian rhythm disorders. The government funds sleep research through the NHMRC and provides public health programs to raise awareness about sleep disorders. Import and export of sleep-wake disorder medications are controlled under pharmaceutical trade and safety regulations. Telehealth services for sleep disorders are supported by Medicare.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Types |
6.1 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021- 2031F |
6.1.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hypernychthemeral Syndrome, 2021- 2031F |
6.1.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Shift Work Disorder, 2021- 2031F |
6.1.6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Jet Lag and Others, 2021- 2031F |
6.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Therapeutic Devices, 2021- 2031F |
6.2.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Nonbenzodiazepines, 2021- 2031F |
6.3.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.3.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.5.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Wellness Centers and Spa, 2021- 2031F |
6.5.6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Import-Export Trade Statistics |
7.1 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Export to Major Countries |
7.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Imports from Major Countries |
8 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
9 Australia Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
9.1 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
10.1 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Australia Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |